Investment
Features
FeesSafety
Academy
More
Pluang+

BrenX leaders to speak at key energy events on decarbonizing industry and advancing thermal storage tech.

Market News
20 Oct 2026
Newsfile Corp
View Source
Bullish
BrenX leaders to speak at key energy events on decarbonizing industry and advancing thermal storage tech.

BrenX Ltd. announced that its executives will participate in three major energy events in October 2026 across Europe and the U.S., focusing on decarbonizing industrial heat and integrating renewable energy solutions. CEO Nir Brenmiller will join a panel on Europe's industrial decarbonization in Amsterdam, while CBO Doron Brenmiller will discuss industrial heat decarbonization at the RTC Summit near Washington, D.C. Additionally, Gilad Walker of Brenmiller Europe will keynote on combining renewable energy with thermal storage in Frankfurt. These appearances coincide with BrenX's progress in deploying its bGen™ thermal energy storage systems, including ongoing commissioning in Israel and projects in Hungary. This highlights BrenX's role in advancing practical, integrated energy solutions for industrial decarbonization.

BrenX leadership's participation in energy events provides context for energy sector activity on Pluang. For readers following energy stocks, here is Pluang's market snapshot as of Oct 21, 2026 02:41 WIB: out of 79 priced US energy stocks, 40 rose and 37 fell. Notable movers include BTU at USD 22.67 with a -4.63% change and a typical hold time of 6 days, ENPH at USD 31.88 up 4.08% with 100% sell order activity and a 72-day hold, and SEDG at USD 32.29 up 3.96% with 93% sell order activity and a 34-day hold.

More News

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
25 minutes ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
1 hour ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
1 hour ago
CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...

Others
Neutral
1 hour ago
Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App